MXCT
MaxCyte, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.28
+1.59%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.23x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.83x
- Price / sales
- 4.25x
- Price / cash flow
- -5.75x
Enterprise value
- Enterprise value
- $43.7M
- EV / sales
- 1.41x
- EV / EBITDA
- -1.35x
- EV / EBIT
- -1.26x
- Market cap
- $132.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026